Driving Vaccine Innovation

We’re developing vaccines for Marburg and Ebola Sudan, two of the world’s deadliest viruses.

Sabin engages in clinical research through partnerships. Sabin’s goal is to enter partnerships that provide broader, timely access to data to improve decision-making in global vaccine development and licensing/pre-qualification strategies and ultimately drive better outcomes for the populations we seek to serve.

We’re convening experts across the science and technology landscape, vaccine development and regulatory science, public-private partnerships and pandemic preparedness to bring new thinking to solve one of the oldest and deadliest diseases – influenza.

We are bringing together big ideas in pursuit of a universally protective influenza vaccine that could save millions of lives.

In 2021, the Sabin-Aspen Vaccine Policy Group examined how lessons from the rapid response to COVID-19 could help reshape vaccine development models.